MC 4232
Alternative Names: MC-1/lisinopril; MC-4232; Pyridoxal phosphate/lisinoprilLatest Information Update: 18 Aug 2014
At a glance
- Originator Medicure
- Class Antihypertensives; Coenzymes; Dipeptides; Ischaemic heart disorder therapies; Picolines
- Mechanism of Action ACE inhibitors; Purinergic P2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diabetic complications; Hypertension
Most Recent Events
- 18 Aug 2014 Discontinued - Phase-II for Diabetic complications in Canada (PO)
- 18 Aug 2014 Discontinued - Phase-II for Hypertension in Canada (PO)
- 26 Sep 2005 Medicure has completed a phase II MATCHED trial in patients with diabetes and hypertension